Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1888
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma ; volume:22 ; number:1 ; day:22 ; month:1 ; year:2021 ; pages:101-115 ; date:1.2021
American journal of clinical dermatology ; 22, Heft 1 (22.1.2021), 101-115, 1.2021
- Urheber
-
Bansal, Ashish
Simpson, Eric L.
Paller, Amy S.
Siegfried, Elaine C.
Blauvelt, Andrew
Bruin-Weller, Marjolein de
Corren, Jonathan
Sher, Lawrence
Guttman-Yassky, Emma
Chen, Zhen
Daizadeh, Nadia
Kamal, Mohamed A.
Shumel, Brad
Mina-Osorio, Paola
Mannent, Leda
Patel, Naimish
Graham, Neil M. H.
Khokhar, Faisal A.
Ardeleanu, Marius
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40257-020-00577-1
- URN
-
urn:nbn:de:101:1-2021032221054805833119
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
22.01.2025, 08:00 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bansal, Ashish
- Simpson, Eric L.
- Paller, Amy S.
- Siegfried, Elaine C.
- Blauvelt, Andrew
- Bruin-Weller, Marjolein de
- Corren, Jonathan
- Sher, Lawrence
- Guttman-Yassky, Emma
- Chen, Zhen
- Daizadeh, Nadia
- Kamal, Mohamed A.
- Shumel, Brad
- Mina-Osorio, Paola
- Mannent, Leda
- Patel, Naimish
- Graham, Neil M. H.
- Khokhar, Faisal A.
- Ardeleanu, Marius
- SpringerLink (Online service)
Ähnliche Objekte (12)
Efficacy of Dupilumab in Atopic Dermatitis: The Patient’s Perspective
Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 Year
Dupilumab is Efficacious in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities
Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry
Dupilumab with Topical Corticosteroids Provides Rapid and Sustained Improvement in Adults with Moderate-to-Severe Atopic Dermatitis Across Anatomic Regions Over 52 Weeks
Publisher Correction to: Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry
Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis
Protein design for industrial strain development : the case of amino acid production
Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion
Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years
Infections in Children Aged 6 Months to 5 Years Treated with Dupilumab in a Placebo-Controlled Clinical Trial of Moderate-to-Severe Atopic Dermatitis
Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6–11 Years of Age with Severe Atopic Dermatitis
Efficacy of Dupilumab in Atopic Dermatitis: The Patient’s Perspective
Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 Year
Dupilumab is Efficacious in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities
Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry
Dupilumab with Topical Corticosteroids Provides Rapid and Sustained Improvement in Adults with Moderate-to-Severe Atopic Dermatitis Across Anatomic Regions Over 52 Weeks
Publisher Correction to: Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry
Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis
Protein design for industrial strain development : the case of amino acid production
Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion
Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years
Infections in Children Aged 6 Months to 5 Years Treated with Dupilumab in a Placebo-Controlled Clinical Trial of Moderate-to-Severe Atopic Dermatitis
Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6–11 Years of Age with Severe Atopic Dermatitis
Efficacy of Dupilumab in Atopic Dermatitis: The Patient’s Perspective
Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 Year
Dupilumab is Efficacious in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities
Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry
Dupilumab with Topical Corticosteroids Provides Rapid and Sustained Improvement in Adults with Moderate-to-Severe Atopic Dermatitis Across Anatomic Regions Over 52 Weeks
Publisher Correction to: Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry
Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis
Protein design for industrial strain development : the case of amino acid production
Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion
Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years
Infections in Children Aged 6 Months to 5 Years Treated with Dupilumab in a Placebo-Controlled Clinical Trial of Moderate-to-Severe Atopic Dermatitis